清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization

促炎细胞因子 巨噬细胞极化 巨噬细胞 医学 炎症 免疫学 癌症研究 细胞生物学 内科学 化学 生物 体外 生物化学
作者
Juan Wang,Jing Wang,Jiuchang Zhong,Hongbin Liu,Weiming Li,Mulei Chen,Li Nan Xu,Wenbin Zhang,Ze Zhang,Zhizhong Wei,Jia Guo,Xinyu Wang,Jianhua Sui,Xingpeng Liu,Sitao Zhang,Xiaodong Wang
出处
期刊:Proceedings of the National Academy of Sciences of the United States of America [National Academy of Sciences]
卷期号:121 (35): e2405845121-e2405845121 被引量:39
标识
DOI:10.1073/pnas.2405845121
摘要

Abstract Background Atherosclerosis is a chronic inflammatory disease of the arterial wall characterized by the accumulation of cholesterol-rich lipoproteins in macrophages. Leucine-rich alpha-2 glycoprotein 1 (LRG1) is a circulating protein associated with inflammation, however, its role in atherosclerosis remains unclear. This study identified its role in macrophage pro-inflammatory differentiation and revealed the relationship between LRG1 and atherosclerosis. Method We evaluated the impact of LRG1 on atherosclerosis progression by analyzing atherosclerotic tissue and serum samples from patients with coronary artery disease (CAD) and healthy individuals and analyzed its role in such a process using two types of mice models: Apoe knock-out mice ( Apoe -/- ) and Apoe and Lrg1 double knock-out mice ( Apoe -/- /Lrg1 -/- ). These mice were fed with a high-fat diet for 16 to 32 weeks to simulate conditions exacerbating atherosclerosis. To examine the effects of inhibiting LRG1 on atherogenesis, we administered intraperitoneal injections of LRG1 neutralizing antibody (50μg/kg) weekly to Apoe -/- mice for 8 weeks. We conducted in vitro assays using bone marrow-derived macrophages isolated from wild-type mice and analyzed transcriptional signatures using RNA sequencing. Additionally, we utilized small molecular inhibitors to validate the signaling pathway through which LRG1 promotes macrophage-driven inflammation. Results LRG1 levels were found to be elevated in patients with atherosclerosis and correlated with higher levels of a plasma pro-inflammatory biomarker high-sensitive C-reactive protein (hsCRP), and several macrophage-related pro-inflammatory markers including CD68, VE-Cadherin and VCAM-1. In a high fat diet induced Apoe -/- mouse atherosclerosis model, the deletion of LRG1 gene significantly delayed atherogenesis progression and reduced levels of macrophage-related pro-inflammatory cytokines. Addition of purified LRG1 to cultured macrophages stimulated those macrophages to pro-inflammatory M1-like polarization regulated by the activation of ERK and JNK pathways. An anti-LRG1 neutralizing antibody effectively blocked LRG1-induced macrophage M1-like polarization in vitro and conferred therapeutic benefits to animals with ApoE deficiency-induced atherosclerosis. Conclusion LRG1 plays an important pro-inflammatory role in atherosclerosis by influencing macrophage polarization towards a pro-inflammatory state. The inhibition of LRG1 with neutralizing antibodies may offer a potential therapeutic strategy for patients with atherosclerosis by mitigating the pro-inflammatory response and delaying disease progression, offering a novel therapy in atherosclerosis management. Translational Perspective Atherosclerosis, a persistent inflammatory condition affecting the arterial wall, serves as the underlying pathophysiological basis for acute ischemic cardiovascular events. The involvement of macrophages is crucial in the advancement of atherosclerosis. In this investigation, heightened levels of plasma LRG1 were observed in individuals with coronary artery disease. Moreover, this study presents initial evidence highlighting LRG1 as a pivotal activator of macrophages, instigating a pro-inflammatory M1 polarization during atherogenesis through the activation of ERK1/2 and JNK pathways. The use of an anti-LRG1 neutralizing antibody demonstrated a delay in atherosclerosis progression in an animal model, suggesting a potential therapeutic target for atherosclerosis treatment. Suppression of LRG1 production could impede atherosclerosis advancement and enhance plaque stability. Utilizing neutralizing antibodies against LRG1 emerges as a promising therapeutic approach for treating atherosclerosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形的灵薇完成签到,获得积分10
6秒前
mickaqi完成签到 ,获得积分10
11秒前
柔弱的妙旋完成签到,获得积分10
20秒前
limengyao完成签到,获得积分10
44秒前
lzm完成签到 ,获得积分10
46秒前
水water完成签到 ,获得积分10
1分钟前
虎子完成签到 ,获得积分10
1分钟前
激情的汲完成签到,获得积分10
1分钟前
小珂完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
Gone完成签到,获得积分10
1分钟前
SciGPT的应助被兰兰不懒采纳,获得10
1分钟前
1分钟前
yc关闭了yc的文献求助
1分钟前
VuuVuu完成签到,获得积分10
2分钟前
顺利的雅旋完成签到,获得积分10
2分钟前
2分钟前
兰兰不懒发布了新的文献求助10
2分钟前
淡淡依霜完成签到 ,获得积分10
2分钟前
廖道罡完成签到,获得积分10
2分钟前
温婉的乐荷完成签到,获得积分10
2分钟前
VuuVuu发布了新的文献求助10
2分钟前
852的应助被LY采纳,获得10
3分钟前
简单完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
isssstwice发布了新的文献求助30
3分钟前
isssstwice完成签到,获得积分10
4分钟前
doudou完成签到,获得积分10
4分钟前
落后的山槐完成签到,获得积分10
4分钟前
5分钟前
LY发布了新的文献求助10
5分钟前
活力尔柳完成签到 ,获得积分10
5分钟前
lilylwy完成签到 ,获得积分0
5分钟前
朝朝的应助被萧雨墨采纳,获得10
5分钟前
单纯的天抒完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577355
关于积分的说明 21852358
捐赠科研通 7788741
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560106
邀请新用户注册赠送积分活动 2482902